Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and stroke prevention.

Maurizio Paciaroni1, Michael Hennerici, Giancarlo Agnelli

  • 1Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Perugia, Italy. maurizio.paciaroni@med.unipg.it

Cerebrovascular Diseases (Basel, Switzerland)
|June 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes.

The New England journal of medicine·2026
Same author

Left atrial enlargement and 1-year cerebrovascular events in subjects without atrial fibrillation: A prospective cohort study.

European journal of internal medicine·2026
Same author

Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience.

International journal of cardiology. Cardiovascular risk and prevention·2026
Same author

Optimising the Caravaggio score: developing a more universally applicable and comprehensive venous thromboembolism risk stratification tool. Author's reply.

European journal of internal medicine·2026
Same author

Right ventricular dysfunction on echocardiography to predict mortality in acute pulmonary embolism: an individual patient data meta-analysis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Point-of-care ultrasonography (POCUS): a substantial help for the internists with some caveats.

European journal of internal medicine·2025
Same journal

JR-ZQSI-NICHE: A Digital Neurosurgical Decision Support System for Spontaneous Intracerebral Hemorrhage.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Variations across Europe in national guidelines and clinical practice regarding screening of cognitive and emotional consequences after aneurysmal subarachnoid hemorrhage.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Intravenous Thrombolysis Before Versus Direct Endovascular Treatment for Acute Ischemic Stroke Due to Large Vessel Occlusion: A Systematic Review and Meta-analysis.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Erratum.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Association between extubation timing and functional outcomes in patients with acute ischemic stroke after endovascular treatment.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same journal

Achieving the 'golden hour': evaluating and optimising the spatial distribution of comprehensive stroke centers in Liaoning Province, China.

Cerebrovascular diseases (Basel, Switzerland)·2026
See all related articles

Statins significantly reduce stroke risk in patients with vascular disease by lowering LDL cholesterol. This meta-analysis shows statins decrease stroke incidence, particularly in those with existing coronary artery disease.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Statins are widely used for coronary artery disease prevention.
  • Recent evidence suggests statins also reduce stroke risk in patients with vascular disease.

Purpose of the Study:

  • To evaluate the effect of statins on stroke risk reduction.
  • To analyze the impact of statin therapy on major vascular events.

Main Methods:

  • Meta-analysis of 90,056 patients from the Cholesterol Treatment Trialists' Collaborators.
  • Analysis of the SPARCL study and Heart Protection Study for secondary stroke prevention.

Main Results:

  • A 17% proportional reduction in first-ever stroke incidence per 1 mmol/l LDL cholesterol reduction.

Related Experiment Videos

  • 8 fewer strokes per 1,000 person-years in patients with coronary artery disease versus 5 fewer in those without.
  • Atorvastatin reduced recurrent cerebrovascular events in the SPARCL study.
  • Statins showed a significant reduction in major vascular events (OR = 0.78) in a mini meta-analysis.

    • Conclusions:

    • Statins effectively reduce stroke incidence, with greater benefit in patients with pre-existing coronary artery disease.
    • The exact mechanism (cholesterol reduction vs. pleiotropic effects) requires further investigation.
    • Statins are beneficial in secondary stroke prevention, significantly reducing major vascular events.